248 related articles for article (PubMed ID: 33042815)
1. Predicting Survival Benefit of Sparing Sentinel Lymph Node Biopsy in Low-Risk Elderly Patients With Early Breast Cancer: A Population-Based Analysis.
Xu L; Wen N; Qiu J; He T; Tan Q; Yang J; Du Z; Lv Q
Front Oncol; 2020; 10():1718. PubMed ID: 33042815
[No Abstract] [Full Text] [Related]
2. An exploratory study of whether axillary lymph node dissection can be avoided in breast cancer patients with positive lymph nodes.
Ren F; Yang C; Liu J; Feng K; Shang Q; Kang X; Zhang R; Li L; Zhao S; Wang X; Wang X
Transl Cancer Res; 2024 Feb; 13(2):935-951. PubMed ID: 38482409
[TBL] [Abstract][Full Text] [Related]
3. Comparison of breast-conserving surgery without radiotherapy and mastectomy in the treatment of elderly patients with early breast cancer: A PSM and SEER database study.
Fu B; Chen X; Liang W; Wang Y; Yao Y; Zhang J
Cancer Med; 2023 Jul; 12(14):15229-15245. PubMed ID: 37269188
[TBL] [Abstract][Full Text] [Related]
4. Can Radiotherapy After Breast-Conserving Surgery be Omitted in Elderly Patients with Early-Stage, Hormone-Receptor Negative Breast Cancer? A Population-Based Study and Proposed Nomogram.
Xu L; Zhou C; Qiu J; Lv Q; Du Z
Adv Ther; 2022 Oct; 39(10):4707-4722. PubMed ID: 35953665
[TBL] [Abstract][Full Text] [Related]
5. The Extent of Axillary Surgery Is Associated With Breast Cancer-specific Survival in T1-2 Breast Cancer Patients With 1 or 2 Positive Lymph Nodes: A SEER-Population Study.
Li S; Liu F; Chen K; Rao N; Xie Y; Su F; Zhu L
Medicine (Baltimore); 2016 Apr; 95(14):e3254. PubMed ID: 27057872
[TBL] [Abstract][Full Text] [Related]
6. Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer.
Li Y; Ma L
BMC Cancer; 2021 Aug; 21(1):965. PubMed ID: 34454451
[TBL] [Abstract][Full Text] [Related]
7. Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer.
Zheng Y; Zhong G; Yu K; Lei K; Yang Q
Front Oncol; 2020; 10():148. PubMed ID: 32133290
[No Abstract] [Full Text] [Related]
8. Effect of T Stages on the Choice of Axillary Evaluation Modality in Breast Cancer Patients With 1-2 Sentinel Lymph Node Metastases.
Liu D; Chang L; Zhao X; Dai L; Cui H; Liu P; Zhai Z; Wu H; Ma X; Kang H
Clin Breast Cancer; 2024 Jan; ():. PubMed ID: 38368246
[TBL] [Abstract][Full Text] [Related]
9. Geriatric Early-Stage Triple-Negative Breast Cancer Patients in Low-risk Population: Omitting Chemotherapy Based on Nomogram.
Zhou C; Xu L; Du Z; Lv Q
Clin Breast Cancer; 2022 Dec; 22(8):771-780. PubMed ID: 36163127
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of further axillary dissection for sentinel lymph node micrometastases in female breast cancer: A competing risk analysis using the SEER database.
Zhou Y; Pu S; Jiang S; Li D; Li S; Liu Y; Ren Y; Hao N
Front Oncol; 2022; 12():1012646. PubMed ID: 36465338
[TBL] [Abstract][Full Text] [Related]
11. Association of Axillary Lymph Node Evaluation With Survival in Women Aged 70 Years or Older With Breast Cancer.
Luo SP; Zhang J; Wu QS; Lin YX; Song CG
Front Oncol; 2020; 10():596545. PubMed ID: 33585213
[TBL] [Abstract][Full Text] [Related]
12. Prognosis and local treatment strategies of breast cancer patients with different numbers of micrometastatic lymph nodes.
Luo S; Fu W; Lin J; Zhang J; Song C
World J Surg Oncol; 2023 Jul; 21(1):202. PubMed ID: 37430331
[TBL] [Abstract][Full Text] [Related]
13. Prognostic analysis of cT1-3N1M0 breast cancer patients who have responded to neoadjuvant therapy undergoing various axillary surgery and breast surgery based on propensity score matching and competitive risk model.
Zhang M; Sun Y; Wu H; Xiao J; Chen W; Wang H; Yang B; Luo H
Front Oncol; 2024; 14():1319981. PubMed ID: 38327751
[TBL] [Abstract][Full Text] [Related]
14. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
15. Predicting the survival benefit of local surgery in patients aged 70 years or older with stage IV breast cancer: A population-based analysis.
Chen YQ; Xu JW; Xu XF; Wang XL; Huo LQ; Wang L; Zhou GH; Gu J
Breast; 2021 Oct; 59():124-134. PubMed ID: 34229127
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer.
Guo LW; Jiang LM; Gong Y; Zhang HH; Li XG; He M; Sun WL; Ling H; Hu X
Cancer Manag Res; 2018; 10():5881-5894. PubMed ID: 30510456
[TBL] [Abstract][Full Text] [Related]
17. Sentinel Node Biopsy Should Not be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone Therapy.
McKevitt E; Cheifetz R; DeVries K; Laws A; Warburton R; Gondara L; Lohrisch C; Nichol A
Ann Surg Oncol; 2021 Oct; 28(11):5950-5957. PubMed ID: 33817760
[TBL] [Abstract][Full Text] [Related]
18. Development of a prognostic nomogram for lymph node positive HR
Cheng X; Jiang J; Liang X; Zheng X
Gland Surg; 2023 Nov; 12(11):1541-1553. PubMed ID: 38107492
[TBL] [Abstract][Full Text] [Related]
19. A novel nomogram and risk classification system for predicting lymph node metastasis of breast mucinous carcinoma: A SEER-based study.
Wu SL; Gai JD; Yu XM; Mao X; Jin F
Cancer Med; 2022 Dec; 11(24):4767-4783. PubMed ID: 35599552
[TBL] [Abstract][Full Text] [Related]
20. A novel nomogram and survival analysis for different lymph node status in breast cancer based on the SEER database.
Teng L; Du J; Yan S; Xu P; Liu J; Zhao X; Tao W
Breast Cancer; 2024 May; ():. PubMed ID: 38802681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
